3-aminobenzamide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoetzer, OJ | 1 |
| Pogrebniak, A | 1 |
| Scholz, M | 1 |
| Pelka-Fleischer, R | 1 |
| Gullis, E | 1 |
| Darsow, M | 1 |
| Nüssler, V | 1 |
| Wilmanns, W | 1 |
| Pettitt, AR | 1 |
| Sherrington, PD | 1 |
| Cawley, JC | 1 |
2 other studies available for 3-aminobenzamide and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Drug-induced apoptosis in chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; B-Lympho | 1999 |
Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Membrane; Cell Size; Cladribine; DNA Fragmentati | 2000 |